4John G, Richard W, Kim M, et al. N-Terminal Pro-B-Type Natriuretic Peptide-Guided treatment for chronic heart failure [ J]. J Am Coll Cardiol, 2010, 55(1):53-60.
5Mueller T, Dieplinger B, Gegenhuber A, et al. Increased plasma concentrations of soluble ST2 are predictive tbr 1-year mortality in patients with acute destabilized heart failure[ J ]. Clin Chem, 2008, 54(4) :752-756.
6Januzzi JL Jr, Peacock WF, Maisel AS, et al. Measurement of the interleukin family member ST2 in patients with aeute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study[ J ]. J Am Coll Cardiol, 2007, 50(7) :607 -613.
7Villacorta H, Masetto AC, Mesquita ET. C-Reactive Protein: an inflammatory marker with prognostic value in patients with decompensated heart failure[ J ]. Arq Bras Cardiol, 2007, 88 ( 5 ) :585 - 589.
8Tamariz L, Hare JM. lntlammatory cytokines in heart failure: roles in aetiology and utility as biomarkers[ J]. Eur Heart J, 2010, 31 (7) :768 - 770.
9Peacock WF, De Marco T, Fonarow GC, et al. Cardiac troponin and outcome in acute heart fallure [ J ]. N Engl J Med, 2008, 358 ( 20 ) : 2117 -2126.
10Lee HG, Bae WH, Kim SH, et al. The clinical usefulness of cardiac troponin i as a marker for severity in patients with congestive heart failure[J]. Korean Circ J, 2000, 30(6) :724 -728.
二级参考文献18
1Jolicoeur EM, Granger CB, Fakunding JL, et al. Bringing cardio- vascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, ang Blood Institute Cell Therapy Working Group meeting[J]. Am Heart J, 2007, 153(5) :732 -742.
2Allen R, Kass M, Glover C, et al. Cellular transplantation: future therapeutic options[J]. Curr Opin Cardiol, 2007,22(2) :104 -110.
3Menasche P. Stem cell therapy for heart failure are arrhythmias a real safety concern? [J]. Circulation, 2009, 119(20) :2735 -2740.
4Seidman JG, Pyeritz RE, Seidman CE. Genetic factors in myocardial diseasep[M]//. Libby P, Bonow RO, Mann DL, et al. Braun- wald's Heart Disease. 8th ed. Philadelphia: Elsevier, 2008 : 111 -123.
5lakoubova OA, Sabstine MS, Rowland CM, et al. Polymorphism in K1F6 gene and benefit from statins after acute coronary syndromes [J]. J Am Coll Cardiol, 2008, 51 (4) :449 -455.
6Liggett SB, Mialet-Perez J, Thaneemit-Chen S, et al. A polymor- phism within an observed bl-adtenergic receptor mitif alters cardiac function and beta blocker response in human heart failure[ J ]. Proc Natl Acad Sci USA, 2006, 103(30) :11288 - 11293.
7Lietz K, Miller LW. hnproved surviral of patients with end-stage heart failure listed for heart transplantation: analysis of organ pro- curement and transplantation network/U. S. United Network of Organ Sharing data, 1990 to 2005 [ J]. J Am Coll Cardiol, 2007, 50 ( 13 ) : 1282 - 1290.
